Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph R Stock

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Bioorganic & Medicinal Chemistry Letters|June 28, 2002
Modification of the swern oxidation: use of a recyclable, polystyrene bound sulfoxideDerek C Cole, Joseph R Stock, Jo Anne Kappel
Journal for Healthcare Quality : Official Publication of the National Association for Healthcare Quality|November 11, 2003
A model structure for an EBM program in a multihospital systemDale N Schumacher, Joseph R Stock, Joan K Richards
Bioorganic & Medicinal Chemistry Letters|December 18, 2004
N1-arylsulfonyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole derivatives are potent and selective 5-HT6 receptor antagonistsDerek C Cole, John W Ellingboe, William J Lennox, et al.
Bioorganic & Medicinal Chemistry Letters|August 30, 2005
Conformationally constrained N1-arylsulfonyltryptamine derivatives as 5-HT6 receptor antagonistsDerek C Cole, William J Lennox, Joseph R Stock, et al.
Chembiochem : a European Journal of Chemical Biology|June 5, 2025
Synthesis of Chemically Diverse siRNA-Lipid Conjugates Enabled by Reversible Adsorption to Solid Support (RASS)Albert Kakkis, Linzhongyi Sun, Zhijie Xie, et al.
Analytical Biochemistry|December 19, 2009
A fluorescent assay suitable for inhibitor screening and vanin tissue quantificationBenfang H Ruan, Derek C Cole, Paul Wu, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 2010
Benzimidazole- and indole-substituted 1,3'-bipyrrolidine benzamides as histamine H3 receptor antagonistsDerek C Cole, Jonathan L Gross, Thomas A Comery, et al.
Journal of Medicinal Chemistry|September 12, 2008
Identification, characterization and initial hit-to-lead optimization of a series of 4-arylamino-3-pyridinecarbonitrile as protein kinase C theta (PKCtheta) inhibitorsDerek C Cole, Magda Asselin, Agnes Brennan, et al.
Journal of Medicinal Chemistry|October 24, 2007
Discovery of N1-(6-chloroimidazo[2,1-b][1,3]thiazole-5-sulfonyl)tryptamine as a potent, selective, and orally active 5-HT(6) receptor agonistDerek C Cole, Joseph R Stock, William J Lennox, et al.
Bioorganic & Medicinal Chemistry Letters|December 11, 2007
Acylguanidine inhibitors of beta-secretase: optimization of the pyrrole ring substituents extending into the S1' substrate binding pocketLee D Jennings, Derek C Cole, Joseph R Stock, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Bioorganic & Medicinal Chemistry Letters|June 28, 2002
Modification of the swern oxidation: use of a recyclable, polystyrene bound sulfoxideDerek C Cole, Joseph R Stock, Jo Anne Kappel
Journal for Healthcare Quality : Official Publication of the National Association for Healthcare Quality|November 11, 2003
A model structure for an EBM program in a multihospital systemDale N Schumacher, Joseph R Stock, Joan K Richards
Bioorganic & Medicinal Chemistry Letters|December 18, 2004
N1-arylsulfonyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole derivatives are potent and selective 5-HT6 receptor antagonistsDerek C Cole, John W Ellingboe, William J Lennox, et al.
Bioorganic & Medicinal Chemistry Letters|August 30, 2005
Conformationally constrained N1-arylsulfonyltryptamine derivatives as 5-HT6 receptor antagonistsDerek C Cole, William J Lennox, Joseph R Stock, et al.
Chembiochem : a European Journal of Chemical Biology|June 5, 2025
Synthesis of Chemically Diverse siRNA-Lipid Conjugates Enabled by Reversible Adsorption to Solid Support (RASS)Albert Kakkis, Linzhongyi Sun, Zhijie Xie, et al.
Analytical Biochemistry|December 19, 2009
A fluorescent assay suitable for inhibitor screening and vanin tissue quantificationBenfang H Ruan, Derek C Cole, Paul Wu, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 2010
Benzimidazole- and indole-substituted 1,3'-bipyrrolidine benzamides as histamine H3 receptor antagonistsDerek C Cole, Jonathan L Gross, Thomas A Comery, et al.
Journal of Medicinal Chemistry|September 12, 2008
Identification, characterization and initial hit-to-lead optimization of a series of 4-arylamino-3-pyridinecarbonitrile as protein kinase C theta (PKCtheta) inhibitorsDerek C Cole, Magda Asselin, Agnes Brennan, et al.
Journal of Medicinal Chemistry|October 24, 2007
Discovery of N1-(6-chloroimidazo[2,1-b][1,3]thiazole-5-sulfonyl)tryptamine as a potent, selective, and orally active 5-HT(6) receptor agonistDerek C Cole, Joseph R Stock, William J Lennox, et al.
Bioorganic & Medicinal Chemistry Letters|December 11, 2007
Acylguanidine inhibitors of beta-secretase: optimization of the pyrrole ring substituents extending into the S1' substrate binding pocketLee D Jennings, Derek C Cole, Joseph R Stock, et al.
Pageof 2